BOUCHERVILLE, QC, Oct. 16, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the appointment of Mr. Louis Laflamme as chairman of the board of directors and the appointment of Mr. Noureddine Mokaddem as a new member of the board of directors.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
